Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cidara Therapeutics Q2 EPS $(0.19) Down From $0.18 YoY

Cidara Therapeutics (NASDAQ:CDTX) reported quarterly losses of $(0.19) per share. This is a 205.56 percent decrease over earnings of $0.18 per share from the same period last year.
byBenzinga Newsdesk
August 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cidara Therapeutics (NASDAQ:CDTX) reported quarterly losses of $(0.19) per share. This is a 205.56 percent decrease over earnings of $0.18 per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts